TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Agrenius Lungmedicin AB
Closing information (x1000 SEK)
| Closing information | 2025/06 | 2024/06 | 2023/06 |
| Turnover |
574
|
605
|
691 |
| Financial expenses |
10
|
0
|
47 |
| Earnings before taxes |
525
|
73
|
62 |
| EBITDA |
-24
|
-4
|
108 |
| Total assets |
3,381
|
3,133
|
3,238 |
| Current assets |
214
|
399
|
293 |
| Current liabilities |
277
|
271
|
175 |
| Equity capital |
2,986
|
2,729
|
2,896 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
0
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Solvency |
88.3%
|
87.1%
|
89.4% |
| Turnover per employee |
605
|
691 | |
| Profit as a percentage of turnover |
91.5%
|
12.1%
|
9.0% |
| Return on assets (ROA) |
15.8%
|
2.3%
|
3.4% |
| Current ratio |
77.3%
|
147.2%
|
167.4% |
| Return on equity (ROE) |
17.6%
|
2.7%
|
2.1% |
| Change turnover |
-31
|
-86
|
-421 |
| Change turnover % |
-5%
|
-12%
|
-38% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/06 | 2024/06 | 2023/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.